75 related articles for article (PubMed ID: 501215)
1. Decreased hepatic microsomal reserve in patients with cirrhosis. Studies using aminopyrine as model drug.
Piken E; Hepner GW
J Lab Clin Med; 1979 Dec; 94(6):947-54. PubMed ID: 501215
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
Miguet JP; Vuitton D; Thebault-Lucas A; Joanne C; Dhumeaux D
Gastroenterology; 1980 May; 78(5 Pt 1):996-1000. PubMed ID: 7380205
[TBL] [Abstract][Full Text] [Related]
3. Pericellular collagen in alcoholics with liver cirrhosis.
Arranto AJ; Rautio A; Sotaniemi EA
Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):121-35. PubMed ID: 7058284
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test.
Urbain D; Muls V; Makhoul E; Jeghers O; Thys O; Ham HR
Am J Gastroenterol; 1993 Jun; 88(6):856-9. PubMed ID: 8503380
[TBL] [Abstract][Full Text] [Related]
5. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test.
Saunders JB; Lewis KO; Paton A
Gastroenterology; 1980 Jul; 79(1):112-4. PubMed ID: 6769747
[TBL] [Abstract][Full Text] [Related]
6. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
von Mandach U; Jost G; Preisig R
Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease.
Rodzynek JJ; Preux C; Leautaud P; Abramovici J; Di Paolo A; Delcourt AA
Arch Intern Med; 1986 Apr; 146(4):677-80. PubMed ID: 3963948
[TBL] [Abstract][Full Text] [Related]
8. Assessment of liver function by the aminopyrine breath test.
Villeneuve JP; Arsène D; Huet PM
Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
[TBL] [Abstract][Full Text] [Related]
9. Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve.
Herold C; Ganslmayer M; Ocker M; Zopf S; Gailer B; Hahn EG; Schuppan D
J Gastroenterol Hepatol; 2003 Apr; 18(4):445-9. PubMed ID: 12653894
[TBL] [Abstract][Full Text] [Related]
10. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
Wensing G; Hoffmann K; Heidemann HT
Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
[TBL] [Abstract][Full Text] [Related]
12. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
[TBL] [Abstract][Full Text] [Related]
13. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
[TBL] [Abstract][Full Text] [Related]
14. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
15. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
[TBL] [Abstract][Full Text] [Related]
16. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the aminopyrine breath test and the Child-Pugh score to urinary sodium retention in patients with liver cirrhosis.
Wensing G; Lotterer E; Ahlsdorf H; Kügler CF; Hahn EG; Fleig WE
Z Gastroenterol; 1995 Mar; 33(3):150-4. PubMed ID: 7754646
[TBL] [Abstract][Full Text] [Related]
18. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
[TBL] [Abstract][Full Text] [Related]
19. Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat.
Wensing G; Sabra R; Branch RA
Z Gastroenterol; 1995 Jan; 33(1):1-4. PubMed ID: 7886979
[TBL] [Abstract][Full Text] [Related]
20. The aminopyrine breath test.
Perri F; Pastore M; Annese V; Andriulli A
Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
